Sorry, but you are not correct in stating that CHM's trial is no better than SoC. You are failing to take into account that yesterday's results are based on prelim data comprising of a single cycle of treatment not six as per the AI data I posted yesterday. Next time, do your due diligence.
On the surface, 2 out of 3 patients with CRi is not earth shattering, and nor is an ORR of 100% (CRi +SD), but in this particular patient group, where CRi is not likely expected after just one cycle, to the likes of Dr Abhishek Maiti, the results are likely extremely promising. And, yes, CRi is not as good as CR but at this stage and in this group, that's to be expected but probably not as early as this. Not that it matters now because as several portended, all but the selected few, have been kicked in the guts once again.
So, Dr Maiti is likely very happy with the results our current trial. How do I know? Well, I was busy watching the interview with him that Krushingit posted yesterday at the time that the false TH got lifted that completely effed up the opportunity to trade out of the mess that i see myself in today. But such is life.
CHM Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)